The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study.

Journal: Neurourology and urodynamics
Published Date:

Abstract

BACKGROUND: Urinary continence (UC) recovery dramatically affects quality of life after robot-assisted radical prostatectomy (RARP). Membranous urethral length (MUL) has been the most studied anatomical variable associated with UC recovery.

Authors

  • Manuela Tutolo
    Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Giuseppe Rosiello
    Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
  • Giorgio Stabile
    Department of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy.
  • Giovanni Tasso
    Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Davide Oreggia
    Department of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy.
  • Liesbeth De Wever
    Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
  • Dirk De Ridder
    Department of Surgical Sciences, Section of Neurosurgery, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. Electronic address: dirk.deridder@otago.ac.nz.
  • Antony Pellegrino
    Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Antonio Esposito
    Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Francesco De Cobelli
    Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Andrea Salonia
    Department of Urology, IRCCS San Raffaele Scientific Institute - Vita-Salute San Raffaele University, Milan, Italy.
  • Alberto Briganti
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Francesco Montorsi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Wouter Everaerts
    Urology, University Hospitals Leuven, Leuven, Belgium.
  • Frank Van Der Aa
    Department of Urology, University of Leuven, Leuven, Belgium.